Humacyte, Inc. (HUMA) Q3 2025 Earnings Call Transcript

November 12, 2025 12:21:36 pm

Source: SeekingAlpha

2025-11-12 12:21:36 ET

Humacyte, Inc. (HUMA) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST

Company Participants

Laura Niklason - Founder, President, CEO & Director
Dale Sander - CFO, Chief Corporate Development Officer & Treasurer
...

For further details see:

Humacyte Inc. Warrant

0.02% G/L:

$0.107 Last:

200 Volume:

$0.10698 Open:

Market Cap $247,325,345

Float 156,832,240

Insiders Ownership N/A

Institutions 62

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City Durham